UNSPSC 51284123: Cefcapene pivoxil

This classification denotes a cephalosporin antibiotic C23H29N5O8S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8I8MJ56XFQ, chemically known as 2,2-dimethylpropanoyloxymethyl (6r,7r)-7-(((z)-2-(2-amino-1,3-thiazol-4-yl)pent-2-enoyl)amino)-3-(carbamoyloxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, but more generally known as cefcapene pivoxil, which bears US NIH Compound Identifier 5282438.

UNSPSC 51284123 Cefcapene pivoxil is a Commodity code for a specific oral antibiotic product. The recent state and local contract opportunities in the source do not align with this code's nominal scope — the two opportunities posted involve doxycycline hyclate, ciprofloxacin hydrochloride, naloxone, and drug deactivation systems, none of which are cefcapene pivoxil. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for antibiotic supply, and Seminole County, Florida issued an IFB for naloxone and drug deactivation systems, but neither procurement references the cefcapene pivoxil product this code represents.

The code shows little relevant recent activity in state and local procurement under its actual commodity classification. When pharmaceutical codes are tagged to state and local opportunities, the match is inconsistent, and this particular code's recent-opportunity record does not support a concrete framing of what state and local governments are actually buying under it. No open solicitations for cefcapene pivoxil appear in the source, and no issuing bodies have posted active opportunities for this product in the timeframe covered. Pursuits should be informed by direct contact with state pharmacy procurement offices and cooperative purchasing consortia such as MMCAP Infuse, which manage piggyback pharmaceutical contracts, rather than reliance on UNSPSC tagging accuracy in this category.